Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Madeline A Lipp"'
Autor:
Jessica L. Kosanovich, Katherine M. Eichinger, Madeline A. Lipp, Sonal V. Gidwani, Devarshi Brahmbhatt, Mark A. Yondola, David H. Chi, Timothy N. Perkins, Kerry M. Empey
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Activated lung ILC2s produce large quantities of IL-5 and IL-13 that contribute to eosinophilic inflammation and mucus production following respiratory syncytial virus infection (RSV). The current understanding of ILC2 activation during RSV infection
Externí odkaz:
https://doaj.org/article/0a90671dc3314c568903c089a58855ff
Autor:
Jessica L. Kosanovich, Katherine M. Eichinger, Madeline A. Lipp, Sonal V. Gidwani, Devarshi Brahmbhatt, Mark A. Yondola, Timothy N. Perkins, Kerry M. Empey
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Respiratory syncytial virus (RSV) is the leading cause of childhood hospitalizations due to bronchiolitis in children under 5 years of age. Moreover, severe RSV disease requiring hospitalization is associated with the subsequent development of wheezi
Externí odkaz:
https://doaj.org/article/728492b18d2242a48eafb2a24939ac4e
Autor:
Katherine N. Killian, Jessica L. Kosanovich, Madeline A. Lipp, Kerry M. Empey, Tim D. Oury, Timothy N. Perkins
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundAsthma is a major public healthcare burden, affecting over 300 million people worldwide. While there has been great progress in the treatment of asthma, subsets of patients who present with airway neutrophilia, often have more severe diseas
Externí odkaz:
https://doaj.org/article/44db0d58f3b0474b9f0a2f542afd9426
Autor:
Katherine M. Eichinger, Jessica L. Kosanovich, Sonal V. Gidwani, Aaron Zomback, Madeline A. Lipp, Timothy N. Perkins, Tim D. Oury, Nikolai Petrovsky, Christopher P. Marshall, Mark A. Yondola, Kerry M. Empey
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Respiratory syncytial virus (RSV) remains the most common cause of lower respiratory tract infections in children worldwide. Development of a vaccine has been hindered by the risk of developing enhanced respiratory disease (ERD) upon natural exposure
Externí odkaz:
https://doaj.org/article/dc7b75cccbe24d529c8492eb0339ddec
Autor:
Madeline A Lipp, Ryan L Crass, Linda J Fitzgerald, Twisha S Patel, Richard H Simon, Blair E Lenhan, MeiLan K Han, Shijing Jia
Publikováno v:
Journal of Antimicrobial Chemotherapy. 77:2516-2521
Objectives Colistimethate sodium and tobramycin are important systemic antibiotics for treatment of cystic fibrosis (CF) pulmonary exacerbations but can induce acute kidney injury (AKI). We characterize the rate of AKI in CF patients treated with sys
Autor:
Paul R. Hartmeier, Jessica L. Kosanovich, Ketki Y. Velankar, Jennifer Armen-Luke, Madeline A. Lipp, Ellen S. Gawalt, Nick Giannoukakis, Kerry M. Empey, Wilson S. Meng
Publikováno v:
Mol Pharm
Nanoparticle formulations have long been proposed as subunit vaccine carriers owing to their ability to entrap proteins and co-deliver adjuvants. Poly(lactic-co-glycolic acid) (PLGA) remains one of the most studied polymers for controlled release and
Autor:
Katherine N. Killian, Jessica L. Kosanovich, Madeline A. Lipp, Kerry M. Empey, Tim D. Oury, Timothy N. Perkins
Publikováno v:
The FASEB Journal. 36
Autor:
Nikolai Petrovsky, Christopher Patrick Marshall, Mark Andrew Yondola, Katherine M. Eichinger, Madeline A. Lipp, Kerry M. Empey, Jessica L. Kosanovich, Timothy N. Perkins
Publikováno v:
Vaccine
Respiratory syncytial virus (RSV) commonly causes severe respiratory tract infections in infants, peaking between 2 and 6 months of age; an age at which direct vaccination is unlikely to be effective. Maternal immunization can deliver high levels of
Autor:
Nikolai Petrovsky, Jessica L. Kosanovich, Katherine M. Eichinger, Kerry M. Empey, Madeline A. Lipp
Publikováno v:
Therapeutic Advances in Vaccines and Immunotherapy, Vol 9 (2021)
Therapeutic Advances in Vaccines and Immunotherapy
Therapeutic Advances in Vaccines and Immunotherapy
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in children worldwide, with the most severe disease occurring in very young infants. Despite half a century of research there still are no licensed RSV vacci
Autor:
Timothy N. Perkins, Jessica L. Kosanovich, Katherine M. Eichinger, Madeline A. Lipp, Kerry M. Empey, Mark Andrew Yondola
Publikováno v:
Vaccine
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections among infants with most infections occurring in the first year of life. Multiple RSV exposures are required for children to mount adult-like immune responses.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::563fbc197c7292a51aeee713962c58b5
https://europepmc.org/articles/PMC7540734/
https://europepmc.org/articles/PMC7540734/